Event information
Fi Europe 2025
2 - 4 December 2025 Paris Expo Porte de Versailles Visit us at stand 71K61About us
CABIO Biotech (Wuhan) Co., Ltd (short for “CABIO”), established in
September 2004, is a high-tech enterprise underpinned by biotechnology and the
first company listed on the Science and Technology Innovation Board (stock
code: 688089) in Hubei Province.
After
nearly two decades of development, CABIO has built a complete technology
transfer platform of industry chain, incorporating directive breeding of
microbial strain, fine regulation of cell, high-efficient separation &
purification, preparation, directional transmission, high-throughput detection &
analysis, among other technology modules. We provide quality functional
ingredients and creative solutions to developers of nutrition and health foods
worldwide. We have achieved the industrialization of arachidonic acid (ARA),
docosahexenoic acid (DHA), β-carotene (BC), N-acetylneuraminic acid and other
products. Our products are widely applied in human nutrition, animal nutrition,
personal care and other fields.
Insisting
on technological innovation as a core motivator, we aim to provide quality
products and creative solutions on the field of human nutrition, animal
nutrition and personal care, obtain high-quality
growth and sustainable development, and create long-term values for customers,
employees, shareholders and other stakeholders.
Specs about this supplier
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Affiliated categories: | Algae |Antioxidant |Colours More |
